Adrenergic agonists, vasopressors and inotropes
Catecholamines and synthetic sympathomimetics, how their receptor profiles predict their effects, the non-adrenergic vasopressors and inotropes, and how to choose between them in shock.
By the end of this page you should be able to
- Classify sympathomimetics by receptor selectivity and by direct or indirect action.
- Describe the pharmacology of adrenaline, noradrenaline, dobutamine, dopamine, isoprenaline, metaraminol and phenylephrine.
- Describe the pharmacology of vasopressin, milrinone and levosimendan.
- Explain why catecholamines are inactive orally and short-acting.
- Choose a vasoactive agent for septic, cardiogenic and anaphylactic shock and justify the choice.
Classification
- Catecholamines (a catechol ring plus an amine): adrenaline, noradrenaline, dopamine (endogenous); dobutamine, isoprenaline (synthetic). Rapidly broken down by COMT and MAO and taken up by neurons: not active orally, half-lives of about 2 minutes, given by infusion.
- Non-catecholamines: phenylephrine, metaraminol, ephedrine, salbutamol. Resistant to COMT, so longer acting and, for some, active orally.
- Direct acting: bind adrenoceptors (adrenaline, noradrenaline, phenylephrine, dobutamine, salbutamol).
- Indirect acting: release noradrenaline from nerve terminals (amphetamine, tyramine) or block its reuptake (cocaine). Show tachyphylaxis as stores run down and are ineffective in depleted states.
- Mixed: ephedrine, metaraminol, dopamine.
Receptor effects to predict from
- Alpha-1 (Gq): arteriolar and venous constriction, raising SVR and venous return; reflex bradycardia; mydriasis.
- Alpha-2 (Gi): presynaptic inhibition of noradrenaline release; central sympatholysis (clonidine, dexmedetomidine).
- Beta-1 (Gs): rate, contractility, conduction, renin. Raises myocardial oxygen demand.
- Beta-2 (Gs): bronchodilation, vasodilation in muscle (lowers diastolic pressure), glycogenolysis, lactate, potassium into cells, uterine relaxation, mast cell stabilisation.
- D1: renal and mesenteric vasodilation (low-dose dopamine, which does not protect the kidney).
The drugs
- Adrenaline: alpha and beta. Low doses: mostly beta (raised cardiac output, lower diastolic pressure from beta-2 vasodilation). High doses: alpha dominates. Uses: cardiac arrest, anaphylaxis (IM; beta-2 also stabilises mast cells and bronchodilates), severe asthma, croup (nebulised), shock refractory to noradrenaline, symptomatic bradycardia. Raises lactate and glucose and lowers potassium.
- Noradrenaline: potent alpha-1 with moderate beta-1, little beta-2. Raises SVR and mean arterial pressure; heart rate often falls (baroreflex); cardiac output roughly unchanged. First-line in septic shock.
- Dobutamine: synthetic, mainly beta-1 with some beta-2 and alpha-1 (the racemate balances out the vascular effects). An inotrope that raises cardiac output and may lower SVR; can cause hypotension and tachyarrhythmias. Used in low-output cardiac failure with adequate blood pressure, and for stress echocardiography.
- Dopamine: dose-dependent: D1 at low doses, beta-1 at moderate doses, alpha-1 at high doses (with indirect noradrenaline release). More arrhythmias than noradrenaline in shock; now rarely first-line.
- Isoprenaline: pure beta-1 and beta-2 agonist. Raises heart rate and conduction (bradycardia, heart block awaiting pacing, torsades) and drops diastolic pressure.
- Metaraminol: direct alpha-1 agonist with indirect noradrenaline release; bolus or infusion, onset 1 to 2 minutes, lasts about 20 minutes. Popular for peri-intubation hypotension in Australasian EDs; reflex bradycardia; tachyphylaxis.
- Phenylephrine: pure alpha-1. Raises pressure with reflex bradycardia; useful when tachycardia is unwanted (hypertrophic obstructive cardiomyopathy, aortic stenosis) and in obstetric spinal hypotension.
- Ephedrine: mixed direct and indirect alpha and beta; raises heart rate and pressure; tachyphylaxis.
Non-adrenergic agents
- Vasopressin: V1 receptors on vascular smooth muscle (Gq) cause vasoconstriction independent of adrenoceptors (useful in acidosis, when catecholamine receptors respond poorly); V2 receptors in the collecting duct (water retention); relative vasopressin deficiency develops in septic shock. Added to noradrenaline to reduce the catecholamine dose. Adverse: digital, mesenteric and coronary ischaemia. Terlipressin is a longer-acting analogue used in variceal bleeding and hepatorenal syndrome.
- Milrinone: phosphodiesterase 3 inhibitor; raises cAMP in heart (inotropy, lusitropy) and vessels (vasodilation): an inodilator. Works when beta receptors are down-regulated or blocked. Renally cleared, long half-life; hypotension and arrhythmias.
- Levosimendan: calcium sensitiser (binds troponin C) and K-ATP opener (vasodilation); active metabolite lasts days.
- Glucagon and high-dose insulin bypass the beta receptor in beta blocker poisoning; calcium in calcium channel blocker poisoning.
- Methylene blue inhibits nitric oxide-cGMP signalling and can raise pressure in vasoplegia; contraindicated in G6PD deficiency and with serotonergic drugs.
Choosing in shock
Start with the problem. Septic (distributive) shock: after fluids, noradrenaline to a mean arterial pressure target (commonly 65 mmHg), adding vasopressin or adrenaline if needed, with hydrocortisone for refractory shock. Cardiogenic shock: the heart is failing and vasoconstriction raises afterload; an inotrope (dobutamine, adrenaline or milrinone) with noradrenaline to support pressure, and treatment of the cause (reperfusion). Anaphylaxis: adrenaline IM first, then infusion if shock persists. Neurogenic shock: noradrenaline (or phenylephrine) with atropine or a beta agonist for bradycardia. Hypovolaemic shock: volume and haemorrhage control; vasopressors only bridge.
Peripheral administration of dilute vasopressors through a large, well-sited cannula for a short time is accepted practice, with close watching for extravasation.
Making the answer flow
- Predict effects from the receptor profile, then add reflexes: "Phenylephrine raises SVR, so pressure rises and the baroreflex slows the heart."
- Distinguish vasopressor (raises SVR) from inotrope (raises contractility) and inodilator (both inotropy and vasodilation).
- Tie the choice to the haemodynamic profile of the shock state.
Where marks are lost
- Saying noradrenaline causes tachycardia. It usually slows the heart through the baroreflex.
- Claiming low-dose dopamine protects the kidneys.
- Forgetting that adrenaline lowers diastolic pressure at low doses (beta-2).
- Calling a raised lactate on adrenaline proof of hypoperfusion.
Where this meets the emergency department
- Peri-intubation hypotension is common in shocked patients; have a vasopressor drawn up before induction.
- Anaphylaxis that does not respond to two or three IM adrenaline doses needs an adrenaline infusion, not more antihistamine.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Compare adrenaline and noradrenaline.
Show answer
- Both endogenous catecholamines; COMT, MAO and reuptake; half-life about 2 minutes; IV infusion.
- Adrenaline: alpha-1, alpha-2, beta-1, beta-2; dose-dependent; raises cardiac output; low dose lowers diastolic BP; metabolic effects (glucose, lactate, potassium down).
- Noradrenaline: alpha predominant with beta-1; raises SVR and MAP; reflex bradycardia; little metabolic effect.
- Uses: adrenaline in arrest and anaphylaxis; noradrenaline in septic shock.
- 2.
Why are catecholamines given intravenously and by infusion?
Show answer
- Polar molecules with a catechol ring: extensive gut and hepatic metabolism by COMT and MAO; negligible oral bioavailability.
- Rapid termination by neuronal reuptake and enzymatic breakdown: half-lives of minutes.
- Infusion gives steady effect and titration; IM adrenaline is an exception for anaphylaxis.
- 3.
A patient with septic shock remains hypotensive on increasing noradrenaline. What are your pharmacological options?
Show answer
- Check volume status, source control, and line function.
- Add vasopressin (non-adrenergic V1 vasoconstriction; corrects relative deficiency; catecholamine-sparing).
- Add adrenaline (inotropy if septic cardiomyopathy).
- Hydrocortisone (restores vascular responsiveness, relative adrenal insufficiency).
- Correct acidosis, calcium; consider methylene blue or angiotensin II in refractory vasoplegia where available.
- 4.
Describe the pharmacology of dobutamine.
Show answer
- Synthetic catecholamine; racemic mixture: (+) is beta-1 and beta-2 agonist and alpha-1 antagonist; (minus) is alpha-1 agonist.
- Net beta-1 effect: increased contractility and cardiac output; modest chronotropy; SVR unchanged or reduced.
- Half-life about 2 minutes; infusion.
- Adverse: tachycardia, arrhythmias, hypotension, myocardial ischaemia; tolerance over days.
- Uses: cardiogenic shock with adequate pressure, stress echocardiography.
- 5.
What is metaraminol and why is it popular in the emergency department?
Show answer
- Synthetic non-catecholamine, direct alpha-1 agonist with indirect noradrenaline release, weak beta.
- Bolus or infusion; onset 1 to 2 minutes; duration about 20 minutes.
- Peripheral use, easy preparation; treats vasodilatory hypotension after induction.
- Limitations: reflex bradycardia, may lower cardiac output in a failing heart, tachyphylaxis, does not treat hypovolaemia.
- 6.
How does milrinone work and when would you use it?
Show answer
- Inhibits PDE3, raising cAMP in myocardium and vascular smooth muscle.
- Positive inotropy and lusitropy with vasodilation (inodilator), lowering SVR and PVR.
- Independent of beta receptors: useful with beta blockade or receptor down-regulation in chronic heart failure; right ventricular failure with pulmonary hypertension.
- Renal elimination; long half-life (hours); hypotension and arrhythmias.
- 7.
Explain the role of vasopressin in shock.
Show answer
- Endogenous peptide from posterior pituitary; V1 (vasoconstriction via Gq and IP3), V2 (aquaporin insertion), V3 (ACTH).
- In septic shock, levels are inappropriately low after the initial surge; vascular response to catecholamines is impaired by acidosis and NO.
- Low-dose infusion restores tone and spares noradrenaline.
- Adverse: digital and splanchnic ischaemia, hyponatraemia, reduced cardiac output.
- 8.
What is tachyphylaxis? Which sympathomimetics show it?
Show answer
- Rapidly diminishing response to repeated doses.
- Indirect agents (ephedrine, metaraminol, amphetamines, tyramine) deplete releasable noradrenaline stores.
- Also receptor desensitisation with prolonged agonist exposure (beta receptors in chronic heart failure or prolonged dobutamine).
- 9.
Why does adrenaline work in anaphylaxis when antihistamines do not?
Show answer
- Alpha-1: vasoconstriction restores SVR and venous return, reduces mucosal oedema.
- Beta-1: inotropy and chronotropy.
- Beta-2: bronchodilation and inhibition of mast cell and basophil mediator release (cAMP).
- Physiological antagonism of all mediators, not just histamine; antihistamines act only at H1 and only on skin symptoms in practice.
- IM into the anterolateral thigh for rapid, reliable absorption.
Practise this week
Week 5 in the other subjects
- Anatomy: Forearm and wrist
- Pathology: Shock
- Physiology: Blood, haemoglobin and haemostasis
Not affiliated with the Australasian College for Emergency Medicine. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.